213 related articles for article (PubMed ID: 18600080)
1. The use of recombinant factor VIIa in liver diseases.
Franchini M; Montagnana M; Targher G; Zaffanello M; Lippi G
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):341-8. PubMed ID: 18600080
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic and therapeutic use of recombinant activated factor VII in patients with cirrhosis and coagulation impairment.
Tsochatzis E; Papatheodoridis GV; Elefsiniotis I; Thanelas S; Theodossiades G; Moulakakis A; Archimandritis AJ
Dig Liver Dis; 2007 May; 39(5):490-4. PubMed ID: 16787769
[TBL] [Abstract][Full Text] [Related]
3. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Murkin JM
Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
[TBL] [Abstract][Full Text] [Related]
4. Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials.
Caldwell SH; Chang C; Macik BG
Hepatology; 2004 Mar; 39(3):592-8. PubMed ID: 14999675
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor VIIa in the treatment of bleeding.
Midathada MV; Mehta P; Waner M; Fink LM
Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
[TBL] [Abstract][Full Text] [Related]
6. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Brady KM; Easley RB; Tobias JD
Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
[TBL] [Abstract][Full Text] [Related]
7. Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices.
Romero-Castro R; Jimenez-Saenz M; Pellicer-Bautista F; Gomez-Parra M; Argüelles Arias F; Guerrero-Aznar MD; Sendon-Perez A; Herrerias-Gutierrez JM
Clin Gastroenterol Hepatol; 2004 Jan; 2(1):78-84. PubMed ID: 15017636
[TBL] [Abstract][Full Text] [Related]
8. Treating coagulopathy in liver disease with plasma transfusions or recombinant factor VIIa: an evidence-based review.
Ramsey G
Best Pract Res Clin Haematol; 2006; 19(1):113-26. PubMed ID: 16377545
[TBL] [Abstract][Full Text] [Related]
9. The role of recombinant-activated factor VII in bleeding trauma patients.
Dutton RP; Conti BM
Curr Opin Anaesthesiol; 2009 Apr; 22(2):299-304. PubMed ID: 19295430
[TBL] [Abstract][Full Text] [Related]
10. [The use of recombinant activated factor VII to control haemorrhage following exenteration and massive transfusion in coagulopathic patients].
Vucelić D; Kecmanović D; Pavlov M; Ranković V; Masirević V; Djukić A; Palibrk I; Tomasević L; Velicković J; Milovanović A
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():231-9. PubMed ID: 19562875
[TBL] [Abstract][Full Text] [Related]
11. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
Fischer D; Schloesser R; Buxmann H; Veldman A
J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
[TBL] [Abstract][Full Text] [Related]
12. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
13. Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders.
Selin S; Tejani A
Issues Emerg Health Technol; 2006 Mar; (82):1-4. PubMed ID: 16602203
[TBL] [Abstract][Full Text] [Related]
14. Activated recombinant factor VII (rFVIIa).
Grottke O; Henzler D; Rossaint R
Best Pract Res Clin Anaesthesiol; 2010 Mar; 24(1):95-106. PubMed ID: 20402173
[TBL] [Abstract][Full Text] [Related]
15. Use of recombinant activated factor VII in a patient with severe thrombocytopenia due to myelodysplastic syndrome with uncontrolled gastrointestinal bleeding.
Ozcelik T; Ozkocaman V; Ozkalemkas F; Ali R; Altundal Y; Ozkan A; Tunali A
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):385-6. PubMed ID: 17473584
[No Abstract] [Full Text] [Related]
16. Recombinant factor VIIa for uncontrolled bleeding in 2 different cases of coagulopathy.
Islam J; Azhar S; Alperin JB; Syed I
J Am Board Fam Pract; 2003; 16(6):549-52. PubMed ID: 14963082
[No Abstract] [Full Text] [Related]
17. The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
Tofil NM; Winkler MK; Watts RG; Noonan J
Pediatr Crit Care Med; 2005 May; 6(3):352-4. PubMed ID: 15857538
[TBL] [Abstract][Full Text] [Related]
18. A reappraisal of plasma, prothrombin complex concentrates, and recombinant factor VIIa in patient blood management.
Goodnough LT
Crit Care Clin; 2012 Jul; 28(3):413-26, vi-vii. PubMed ID: 22713615
[TBL] [Abstract][Full Text] [Related]
19. Use of recombinant activated factor VII to arrest uncontrolled bleeding: a case series.
Alsayegh F; Fakeir A; Alhumood S; Abdumalek K; Matar H; Samaul I; Nampoory N; Kabalawi H; Mousa SA
Clin Appl Thromb Hemost; 2009; 15(2):225-32. PubMed ID: 18160562
[TBL] [Abstract][Full Text] [Related]
20. "Off-license" use of recombinant activated factor VII.
Ghorashian S; Hunt BJ
Blood Rev; 2004 Dec; 18(4):245-59. PubMed ID: 15501553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
